Lenalidomide kills multiple myeloma cells by inducing the IKZF1 and IKZF3 ubiquitination, causing the proteasomal degradation of both IKZF1 and IKZF3 B-cell transcription factors5. This evidence concerns the gene IKZF1 and plasma cell myeloma.